Replies to post #71454 on Ariad Pharmaceuticals Inc fka ARIA

[Jesspro]

Sully, I concur with your post 100%. Zacks's opinion is worth considering too.

"Meanwhile, Ariad Pharmaceuticals is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term.

In fact, over the past month, current quarter estimates have narrowed from a loss of 30 cents per share to a loss of 28 cents per share, while current year estimates have narrowed from a loss of $1.21 per share to a loss of $1.20 per share. The company currently holds a Zacks Rank #3 (Hold), which is also a favorable signal."

[flexinvester]

Sully, your post is right on and I totally support your conclusions. The last source in the world I would believe or who had credibility are the likes of RBC and BMO as they have an agenda which is absolutely biased in helping themselves and clients/partners alike. Watch what is happening right now and that is accumulation at artificially low levels (games too for that matter). Just remember that this was trading in 2013 over $20 with worse fundamentals. "They" (insiders and institutions) know something and follow the big, smart money. IMHO